![](https://www.canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZ29CIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--267e350c54eebf58648a51dfa0df371dab7853e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/Tizona-Logo-PMS-2945-421.png)
Tizona Therapeutics
Tizona is offering next-generation cancer immunotherapy with its anti-HLA-G antibody.
Website
tizonatx.comPartner
Nina KjellsonInvestment
Series B
Tizona is offering next-generation cancer immunotherapy with its anti-HLA-G antibody.
Series B